Menu
Back to User profile » Dr Asif Khan
Papers published by Dr Asif Khan:
Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma
Gurnell M, Radwan A, Bachert C, Lugogo N, Cho SH, Nash S, Zhang H, Khan AH, Jacob-Nara JA, Rowe PJ, Deniz Y
Journal of Asthma and Allergy 2024, 17:1-8
Published Date: 16 January 2024
Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics
Busse WW, Pavord ID, Siddiqui S, Khan AH, Praestgaard A, Nash S, Jacob-Nara JA, Rowe PJ, Deniz Y
Journal of Asthma and Allergy 2023, 16:411-419
Published Date: 18 April 2023
Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial
Maspero JF, Khan AH, Philpott C, Hellings PW, Hopkins C, Wagenmann M, Siddiqui S, Msihid J, Nash S, Chuang CC, Kamat S, Rowe PJ, Deniz Y, Jacob-Nara JA
Journal of Asthma and Allergy 2023, 16:323-332
Published Date: 29 March 2023
Content Validation of Patient-Reported Sleep Measures and Development of a Conceptual Model of Sleep Disturbance in Patients with Moderate-to-Severe, Uncontrolled Asthma
Khan AH, Kosa K, De Prado Gomez L, Whalley D, Kamat S, Clark M
Patient Related Outcome Measures 2023, 14:57-71
Published Date: 23 March 2023
Impact of Baseline Lung Function on Future Exacerbations in Patients with Moderate-to-Severe Asthma
Khan AH, Gray C, Eckert L, Amand C, Maroni J, Wang Z, Jones B, Berni T, Morgan CL, Rowe PJ
Journal of Asthma and Allergy 2022, 15:1639-1644
Published Date: 11 November 2022
Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST Study
Hopkins C, Buchheit KM, Heffler E, Cohen NA, Olze H, Khan AH, Msihid J, Siddiqui S, Nash S, Jacob-Nara JA, Rowe PJ, Deniz Y
Journal of Asthma and Allergy 2022, 15:767-773
Published Date: 7 June 2022
Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNP
Bachert C, Khan AH, Hopkins C, Blaiss MS, Soler ZM, Nash S, Siddiqui S, Praestgaard A, Deniz Y, Rowe PJ, Jacob-Nara JA
Journal of Asthma and Allergy 2022, 15:557-563
Published Date: 4 May 2022
Data Mining of Free-Text Responses: An Innovative Approach to Analyzing Patient Perspectives on Treatment for Chronic Rhinosinusitis with Nasal Polyps in a Phase IIa Proof-of-Concept Study for Dupilumab
Khan AH, Abbe A, Falissard B, Carita P, Bachert C, Mullol J, Reaney M, Chao J, Mannent LP, Amin N, Mahajan P, Pirozzi G, Eckert L
Patient Preference and Adherence 2021, 15:2577-2586
Published Date: 19 November 2021
Association Between a Type 2 Inflammatory Disease Burden Score and Outcomes Among Patients with Asthma
Price D, Menzies-Gow A, Bachert C, Canonica GW, Kocks J, Khan AH, Ye F, Rowe PJ, Lu Y, Kamat S, Carter V, Voorham J
Journal of Asthma and Allergy 2021, 14:1173-1183
Published Date: 29 September 2021
Reducing Fungal Exposure Critical for Treating Rhinosinusitis with or without Polyps [Response to Letter]
Bachert C, Bhattacharyya N, Desrosiers M, Khan AH
Journal of Asthma and Allergy 2021, 14:393-395
Published Date: 19 April 2021
Burden of Disease in Chronic Rhinosinusitis with Nasal Polyps
Bachert C, Bhattacharyya N, Desrosiers M, Khan AH
Journal of Asthma and Allergy 2021, 14:127-134
Published Date: 11 February 2021